Company Filing History:
Years Active: 2013
Title: Ramin Tadayoni: Innovator in Angiogenesis Modulation
Introduction
Ramin Tadayoni is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the modulation of angiogenesis. His work focuses on innovative methods that have the potential to impact therapeutic approaches for various conditions.
Latest Patents
Ramin Tadayoni holds a patent titled "Methods for modulating angiogenesis via dystrophin Dp71." This invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention highlights the role of Dp71 in angiogenesis and provides novel therapeutic approaches. It also introduces methods for screening agents that modulate angiogenesis, specifically targeting this protein. More precisely, the invention discusses the use of Dp71 or its variants for stimulating angiogenesis in subjects, particularly humans. Additionally, it covers the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject.
Career Highlights
Ramin Tadayoni is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he continues to advance his research. His work has garnered attention for its potential applications in medical therapies.
Collaborations
Ramin collaborates with esteemed colleagues, including Romain Bernard and Bénédicte Dupas, who contribute to his research endeavors.
Conclusion
Ramin Tadayoni's innovative work in angiogenesis modulation represents a significant advancement in medical research. His patent and ongoing contributions have the potential to lead to new therapeutic strategies for various health conditions.